The probabilistic model of Alzheimer disease: the amyloid hypothesis revised

GB Frisoni, D Altomare, DR Thal, F Ribaldi… - Nature Reviews …, 2022 - nature.com
The current conceptualization of Alzheimer disease (AD) is driven by the amyloid
hypothesis, in which a deterministic chain of events leads from amyloid deposition and then …

Microglial phagocytosis: a disease-associated process emerging from Alzheimer's disease genetics

A Podleśny-Drabiniok, E Marcora, AM Goate - Trends in Neurosciences, 2020 - cell.com
Alzheimer's disease (AD) is a debilitating, chronic neurodegenerative disease. Genetic
studies involving genome-wide association studies (GWAS) and meta-analysis have …

Impact of HMGB1, RAGE, and TLR4 in Alzheimer's disease (AD): from risk factors to therapeutic targeting

YN Paudel, E Angelopoulou, C Piperi, I Othman… - Cells, 2020 - mdpi.com
Alzheimer's disease (AD) is a devastating neurodegenerative disorder and a leading cause
of dementia, with accumulation of amyloid-beta (Aβ) and neurofibrillary tangles (NFTs) as …

Microglia in Alzheimer's disease: Pathogenesis, mechanisms, and therapeutic potentials

J Miao, H Ma, Y Yang, Y Liao, C Lin, J Zheng… - Frontiers in aging …, 2023 - frontiersin.org
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by protein
aggregation in the brain. Recent studies have revealed the critical role of microglia in AD …

Protective genes and pathways in Alzheimer's disease: moving towards precision interventions

M Seto, RL Weiner, L Dumitrescu… - Molecular …, 2021 - Springer
Alzheimer's disease (AD) is a progressive, neurodegenerative disorder that is characterized
by neurodegeneration, cognitive impairment, and an eventual inability to perform daily tasks …

Rab GTPases: switching to human diseases

NA Guadagno, C Progida - Cells, 2019 - mdpi.com
Rab proteins compose the largest family of small GTPases and control the different steps of
intracellular membrane traffic. More recently, they have been shown to also regulate cell …

Polyphenols isolated from lychee seed inhibit Alzheimer's disease-associated Tau through improving insulin resistance via the IRS-1/PI3K/Akt/GSK-3β pathway

R Xiong, XL Wang, JM Wu, Y Tang, WQ Qiu… - Journal of …, 2020 - Elsevier
Ethnopharmacological relevance Lychee seed, the seed of Litchi chinensis Sonn. is one of
the commonly used in traditional Chinese medicine (TCM). It possesses many …

Cellular and subcellular localization of Rab10 and phospho-T73 Rab10 in the mouse and human brain

V Singh, MA Menard, GE Serrano, TG Beach… - Acta Neuropathologica …, 2023 - Springer
Autosomal dominant pathogenic mutations in Leucine-rich repeat kinase 2 (LRRK2) cause
Parkinson's disease (PD). The most common mutation, G2019S-LRRK2, increases the …

Perspectives for new and more efficient multifunctional ligands for Alzheimer′ s disease therapy

A Zagórska, A Jaromin - Molecules, 2020 - mdpi.com
Despite tremendous research efforts at every level, globally, there is still a lack of effective
drugs for the treatment of Alzheimer′ s disease (AD). The biochemical mechanisms of this …

Dissecting Alzheimer's disease pathogenesis in human 2D and 3D models

G Cenini, M Hebisch, V Iefremova, LJ Flitsch… - Molecular and Cellular …, 2021 - Elsevier
The incidence of Alzheimer's disease is increasing with the aging population, and it has
become one of the main health concerns of modern society. The dissection of the underlying …